Fulgent Diagnostics to Implement Golden Helix's VSPipeline to Speed Analysis & Interpretation Process
Bozeman, MT (July 22, 2015) — Today, Golden Helix, Inc. announces their collaboration with Fulgent Diagnostics as they prepare to integrate VSPipeline into their current bioinformatics pipeline.
"We are looking forward to integrating VSPipeline into our bioinformatics and interpretation processes to further speed up our data analysis process," said Bill Scaringe, Director of Bioinformatics at Fulgent Diagnostics.
"VSPipeline is our next evolution in serving our clinical users," said Andreas Scherer, President and CEO of Golden Helix. "VSPipeline helps high throughput labs like Fulgent Diagnostics, to reach their growth goals by automating the entire tertiary analysis process, saving time and allowing them to scale to higher demands."
VarSeq software streamlines the process of annotating and filtering variants obtained from NGS pipelines, allowing both research scientists and clinicians to find variants of interest in a very efficient and straightforward manner. VarSeq simplifies the user interface and provides a scalable architecture featuring repeatable workflows, note taking, reporting, and filter parameter prototyping.
VSPipeline allows you to create workflow-encoded project templates which lock down quality control and filtering parameters, automating your pipeline and providing you with the requirements needed for CLIA and CAP certified analysis. Out of your automated pipeline will come fully produced VarSeq projects, ready for the technical and medical staff to jump into variant interpretation and reporting.
About Golden Helix
Golden Helix has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over 16 years. Our innovative technologies and analytic services empower scientists and healthcare
professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from micro-arrays and DNA sequencing. With our solutions, hundreds of the world's top pharmaceutical, biotech, and academic research organizations
are able to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have
been cited in over 800 peer-reviewed publications.
About Fulgent Diagnostics
Fulgent Diagnostics, a CLIA certified high complexity molecular diagnostics lab, offers 4,000+ single gene tests, 170+ preset panels, including a Clinical Exome panel. In addition, Fulgent enables customers to easily order custom NGS panels. Most
importantly, Fulgent Diagnostics provides flexibility, high quality testing, and affordable pricing.
Cheryl Rogers
Director of Marketing
Golden Helix, Inc.
406-585-8137
rogers@goldenhelix.com
Jakub Sram, PhD, MBA
Director of Business Development
Fulgent Diagnostics
626-755-6833
jsram@fulgentdiagnostics.com